[Elsevier] Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries

hpardo Post time 2024-4-27 00:11:39 | Show all posts |Read mode
Reward20points

Edited by hpardo at 2024-4-27 15:24

Authors: Arango C, Buitelaar JK, Fegert JM, et al.
Title: Safety and efficacy of agomelatine in children and adolescents with major depressive disorder receiving psychosocial counselling: a double-blind, randomised, controlled, phase 3 trial in nine countries
Journal: Lancet Psychiatry, 9(2):113-124 (2022)
DOI: 10.1016/S2215-0366(21)00390-4
https://doi.org/10.1016/S2215-0366(21)00390-4

Best Answer

Reply

Use magic Donate Report

All Reply1 Show all posts
Med9210 Post time 2024-4-27 00:11:40 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report


Intermediate member
  • post

  • reply

  • points

    460

Latest Reply



Return to the list